Berry Genomics Co.,Ltd (SHE:000710)

Market Cap	3.70B -42.1%
Revenue (ttm)	941.16M -15.1%
Net Income	-255.38M
EPS	-0.72
Shares Out	353.52M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,057,600
Average Volume	8,466,307
Open	10.68
Previous Close	10.48
Day's Range	10.35 - 10.70
52-Week Range	9.77 - 17.37
Beta	0.66
RSI	45.06
Earnings Date	Apr 29, 2026

About Berry Genomics Co.,Ltd

Berry Genomics Co.,Ltd, a genomics and life science company, develops and commercializes of genetic test technologies in clinical applications in China. The company offers non-invasive DNA prenatal testing service, genetic disease testing, tumor genetic testing, NextSeq CN500 gene sequencer, and laboratory solutions. It also provides technology services, such as human genome sequencing, transcriptional regulation, single cell/spatial sequencing, animal and plant genome resequencing, genome denovo sequencing, and microbial sequencing, as well a...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2010
• Employees: 1,402
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000710

Financial Performance

In 2024, Berry Genomics Co.,Ltd's revenue was 1.08 billion, a decrease of -6.36% compared to the previous year's 1.15 billion. Losses were -192.43 million, -54.96% less than in 2023.